ABIN152088

antibody from antibodies-online

Targeting: VEGFA VEGF, VEGF-A, VPF

Western blot (Supportive data in Antibodypedia)

ELISA (Recommended by provider)

Immunocytochemistry (Data presented on provider website)

Immunohistochemistry (Supportive data in Antibodypedia)

Flow cytometry (Supportive data in Antibodypedia)

Antibody Data

Product number

ABIN152088

Provider

antibodies-online

Product name

anti-Vascular Endothelial Growth Factor (VEGF) antibody

Antibody type

Monoclonal

Description

Protein G purified

Reactivity

Human, Mouse, Rat, Canine

Host

Mouse

Isotype

IgG

Antibody clone number

VG1

Vial size

0.1 mg

Storage

Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

Handling

Avoid freeze-thaw cycles

References

Submitted references

Enhancement of bone regeneration with the accordion technique via HIF-1α/VEGF activation in a rat distraction osteogenesis model.

Xu J, Sun Y, Wu T, Liu Y, Shi L, Zhang J, Kang Q, Chai Y, Li G
Journal of tissue engineering and regenerative medicine 2018 Feb;12(2):e1268-e1276

---

Immunohistochemical studies and fluorodeoxyglucose uptake on positron emission tomography in pharyngeal cancer for predicting radiotherapy-based treatment outcomes.

Lin YC, Chen RY, Chen SW, Hsieh TC, Yen KY, Liang JA, Yang SN, Wang YC, Chen YH, Chow NH, Kao CH
Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery 2017 Jun;42(3):608-619

---

Disrupting VEGF-A paracrine and autocrine loops by targeting SHP-1 suppresses triple negative breast cancer metastasis.

Su JC, Mar AC, Wu SH, Tai WT, Chu PY, Wu CY, Tseng LM, Lee TC, Chen KF, Liu CY, Chiu HC, Shiau CW
Scientific reports 2016 Jul 1;6:28888

---

Bilirubin modulated cytokines, growth factors and angiogenesis to improve cutaneous wound healing process in diabetic rats.

Ram M, Singh V, Kumawat S, Kant V, Tandan SK, Kumar D
International immunopharmacology 2016 Jan;30:137-149

---

Immunohistochemical overexpression of hypoxia-induced factor 1α associated with slow reduction in ¹⁸fluoro-2-deoxy-D-glucose uptake for chemoradiotherapy in patients with pharyngeal cancer.

Chen SW, Lin YC, Chen RY, Hsieh TC, Yen KY, Liang JA, Yang SN, Wang YC, Chen YH, Chow NH, Kao CH
European journal of nuclear medicine and molecular imaging 2016 Dec;43(13):2343-2352

---

Hyperbranched polyglycerol is superior to glucose for long-term preservation of peritoneal membrane in a rat model of chronic peritoneal dialysis.

Du C, Mendelson AA, Guan Q, Dairi G, Chafeeva I, da Roza G, Kizhakkedathu JN
Journal of translational medicine 2016 Dec 13;14(1):338

---

Upregulating Hif-1α by Hydrogel Nanofibrous Scaffolds for Rapidly Recruiting Angiogenesis Relative Cells in Diabetic Wound.

Chen H, Jia P, Kang H, Zhang H, Liu Y, Yang P, Yan Y, Zuo G, Guo L, Jiang M, Qi J, Liu Y, Cui W, Santos HA, Deng L
Advanced healthcare materials 2016 Apr 20;5(8):907-18

---

Novel Etoposide Analogue Modulates Expression of Angiogenesis Associated microRNAs and Regulates Cell Proliferation by Targeting STAT3 in Breast Cancer.

Srinivas C, Ramaiah MJ, Lavanya A, Yerramsetty S, Kavi Kishor PB, Basha SA, Kamal A, Bhadra U, Bhadra MP
PloS one 2015;10(11):e0142006

---

HIF-1α disturbs osteoblasts and osteoclasts coupling in bone remodeling by up-regulating OPG expression.

Shao J, Zhang Y, Yang T, Qi J, Zhang L, Deng L
In vitro cellular & developmental biology. Animal 2015 Sep;51(8):808-14

---

Hypoxia-Inducible Factor-1α Is Associated With Sprouting Angiogenesis in the Murine Laser-Induced Choroidal Neovascularization Model.

André H, Tunik S, Aronsson M, Kvanta A
Investigative ophthalmology & visual science 2015 Oct;56(11):6591-604

---

Deferoxamine modulates cytokines and growth factors to accelerate cutaneous wound healing in diabetic rats.

Ram M, Singh V, Kumawat S, Kumar D, Lingaraju MC, Uttam Singh T, Rahal A, Tandan SK, Kumar D
European journal of pharmacology 2015 Oct 5;764:9-21

---

Drug-induced hypothermia as beneficial treatment before and after cerebral ischemia.

Johansen FF, Hasseldam H, Rasmussen RS, Bisgaard AS, Bonfils PK, Poulsen SS, Hansen-Schwartz J
Pathobiology : journal of immunopathology, molecular and cellular biology 2014;81(1):42-52

---

A Chinese 2-herb formula (NF3) promotes hindlimb ischemia-induced neovascularization and wound healing of diabetic rats.

Tam JC, Ko CH, Lau KM, To MH, Kwok HF, Chan YW, Siu WS, Etienne-Selloum N, Lau CP, Chan WY, Leung PC, Fung KP, Schini-Kerth VB, Lau CB
Journal of diabetes and its complications 2014 Jul-Aug;28(4):436-47

---

Atorvastatin for ovarian torsion: effects on follicle counts, AMH, and VEGF expression.

Parlakgumus HA, Aka Bolat F, Bulgan Kilicdag E, Simsek E, Parlakgumus A
European journal of obstetrics, gynecology, and reproductive biology 2014 Apr;175:186-90

---

Peroxisome proliferator-activated receptor δ agonist, HPP593, prevents renal necrosis under chronic ischemia.

Fedorova LV, Sodhi K, Gatto-Weis C, Puri N, Hinds TD Jr, Shapiro JI, Malhotra D
PloS one 2013;8(5):e64436

---

β-Cell regeneration mediated by human bone marrow mesenchymal stem cells.

Milanesi A, Lee JW, Li Z, Da Sacco S, Villani V, Cervantes V, Perin L, Yu JS
PloS one 2012;7(8):e42177

---

A phase 1 dose escalation, pharmacokinetic, and pharmacodynamic evaluation of eIF-4E antisense oligonucleotide LY2275796 in patients with advanced cancer.

Hong DS, Kurzrock R, Oh Y, Wheler J, Naing A, Brail L, Callies S, André V, Kadam SK, Nasir A, Holzer TR, Meric-Bernstam F, Fishman M, Simon G
Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Oct 15;17(20):6582-91

---

Antisense-mediated inhibition of survivin, hTERT and VEGF in bladder cancer cells in vitro and in vivo.

Kunze D, Wuttig D, Kausch I, Blietz C, Blumhoff L, Burmeister Y, Kraemer K, Fuessel S, Toma M, Schwenzer B, Meye A, Grimm MO, Hakenberg OW, Jocham D, Wirth MP
International journal of oncology 2008 May;32(5):1049-56

---

Positive feedback between vascular endothelial growth factor-A and autotaxin in ovarian cancer cells.

Ptaszynska MM, Pendrak ML, Bandle RW, Stracke ML, Roberts DD
Molecular cancer research : MCR 2008 Mar;6(3):352-63

---

Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression.

Couvelard A, O'Toole D, Turley H, Leek R, Sauvanet A, Degott C, Ruszniewski P, Belghiti J, Harris AL, Gatter K, Pezzella F
British journal of cancer 2005 Jan 17;92(1):94-101

---

Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification.

Van der Auwera I, Van Laere SJ, Van den Eynden GG, Benoy I, van Dam P, Colpaert CG, Fox SB, Turley H, Harris AL, Van Marck EA, Vermeulen PB, Dirix LY
Clinical cancer research : an official journal of the American Association for Cancer Research 2004 Dec 1;10(23):7965-71

---

Vascular endothelial growth factor in inflammatory bowel disease.

Kapsoritakis A, Sfiridaki A, Maltezos E, Simopoulos K, Giatromanolaki A, Sivridis E, Koukourakis MI
International journal of colorectal disease 2003 Sep;18(5):418-22

---

Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.

Giatromanolaki A, Sivridis E, Maltezos E, Papazoglou D, Simopoulos C, Gatter KC, Harris AL, Koukourakis MI
Journal of clinical pathology 2003 Mar;56(3):209-13

---

DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer.

Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Wykoff CC, Gatter KC, Harris AL
The Journal of pathology 2003 Jun;200(2):222-8

---

Vascular endothelial growth factor (VEGF) expression in operable gallbladder carcinomas.

Giatromanolaki A, Koukourakis MI, Simopoulos C, Polychronidis A, Sivridis E
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2003 Dec;29(10):879-83

---

Arterio-venous gradients of IL-6, plasma and serum VEGF and D-dimers in human cancer.

Salgado R, Benoy I, Weytjens R, Van Bockstaele D, Van Marck E, Huget P, Hoylaerts M, Vermeulen P, Dirix LY
British journal of cancer 2002 Dec 2;87(12):1437-44

---

Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways.

Giatromanolaki A, Koukourakis MI, Sivridis E, O'Byrne K, Cox G, Thorpe PE, Gatter KC, Harris AL
Clinical cancer research : an official journal of the American Association for Cancer Research 2000 May;6(5):1917-21

---

Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer.

Koukourakis MI, Giatromanolaki A, Thorpe PE, Brekken RA, Sivridis E, Kakolyris S, Georgoulias V, Gatter KC, Harris AL
Cancer research 2000 Jun 1;60(11):3088-95

---

Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.

Adams J, Carder PJ, Downey S, Forbes MA, MacLennan K, Allgar V, Kaufman S, Hallam S, Bicknell R, Walker JJ, Cairnduff F, Selby PJ, Perren TJ, Lansdown M, Banks RE
Cancer research 2000 Jun 1;60(11):2898-905

---

The 121 amino acid isoform of vascular endothelial growth factor is more strongly tumorigenic than other splice variants in vivo.

Zhang HT, Scott PA, Morbidelli L, Peak S, Moore J, Turley H, Harris AL, Ziche M, Bicknell R
British journal of cancer 2000 Jul;83(1):63-8

---

Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.

O'Byrne KJ, Koukourakis MI, Giatromanolaki A, Cox G, Turley H, Steward WP, Gatter K, Harris AL
British journal of cancer 2000 Apr;82(8):1427-32

---

Assessment of vascular maturation in non-small cell lung cancer using a novel basement membrane component, LH39: correlation with p53 and angiogenic factor expression.

Kakolyris S, Giatromanolaki A, Koukourakis M, Leigh IM, Georgoulias V, Kanavaros P, Sivridis E, Gatter KC, Harris AL
Cancer research 1999 Nov 1;59(21):5602-7

---

Expression of VEGF in routinely fixed material using a new monoclonal antibody VG1.

Turley H, Scott PA, Watts VM, Bicknell R, Harris AL, Gatter KC
The Journal of pathology 1998 Nov;186(3):313-8

---

Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.

Giatromanolaki A, Koukourakis MI, Kakolyris S, Turley H, O'Byrne K, Scott PA, Pezzella F, Georgoulias V, Harris AL, Gatter KC
Clinical cancer research : an official journal of the American Association for Cancer Research 1998 Dec;4(12):3017-24

Western blot

Supportive validation

Submitted by

antibodies-online (provider)

Main image

Experimental details

WB

Supportive validation

Submitted by

antibodies-online (provider)

Main image

Experimental details

WB

Immunohistochemistry

Supportive validation

Submitted by

antibodies-online (provider)

Main image

Experimental details

IHC

Flow cytometry

Supportive validation

Submitted by

antibodies-online (provider)

Main image

Experimental details

FACS

Supportive validation

Submitted by

antibodies-online (provider)

Main image

Experimental details

FACS

Supportive validation

Submitted by

antibodies-online (provider)

Main image

Experimental details

FACS